Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 46,800 shares at $61.52 ($2.9M) on 2025-05-30, disclosed to the SEC on 2025-06-03.
Scheduled sale ($2.9M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.93 | 4,407 | $269K | 9.3% |
| 2 | $60.93 | 4,407 | $269K | 9.3% |
| 3 | $61.52 | 18,993 | $1.2M | 40.7% |
| 4 | $61.52 | 18,993 | $1.2M | 40.7% |
| Total | $61.41 avg | 46,800 | $2.9M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |